The views expressed in this chapter are those of the authors and do not necessarily represent the views or the opinions of Medicines Control Agency, other regulatory authorities or any of their advisory committees.
CITATION STYLE
Shah, R. R., & Branch, S. K. (2003). Regulatory Requirements for the Development of Chirally Active Drugs (pp. 379–399). https://doi.org/10.1007/978-3-642-55842-9_16
Mendeley helps you to discover research relevant for your work.